Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Butyrylcholinesterase (BChE), also known as pseudocholinesterase, is a nonspecific cholinesterase enzyme that hydrolyzes a wide range of choline-based esters. Primarily synthesized in the liver and found in blood plasma, it plays a crucial role in drug metabolism and detoxification. Genetic deficiencies can lead to prolonged effects of certain anesthetics. BChE is also implicated in various diseases, including Alzheimer's disease and cocaine addiction, making it a potential therapeutic target.
Hydrolyzes ester bonds, leading to inactivation/breakdown of substrate drugs and toxins. Recombinant forms or gene therapy approaches are also used to sequester substrates such as cocaine.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Butyrylcholinesterase (BCHE).